A Review on the Evolving Role of Radiation Therapy in the Treatment of Locally Advanced Rectal Cancer

Treatment of locally advanced rectal cancer (LARC), clinical stages II–III, typically involves multimodal treatment options. Over the past decade, the role of radiation therapy as a neoadjuvant treatment for LARC has evolved and is currently a part of total neoadjuvant therapy (TNT). Some recently p...

Full description

Bibliographic Details
Published in:	Current Oncology
Main Authors:	Zeinab Dandash, Tala Mobayed, Sally Temraz, Ali Shamseddine, Samer Doughan, Samer Deeba, Zeina Ayoub, Toufic Eid, Bassem Youssef, Lara Hilal
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	locally advanced rectal cancer total neoadjuvant therapy non-operative management omission of RT short- versus long-course chemoradiation personalized treatment
Online Access:	https://www.mdpi.com/1718-7729/32/8/443

Similar Items

Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01)

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors
by: Han-Gil Kim, et al.
Published: (2021-01-01)

Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
by: Yuhong Chen, et al.
Published: (2022-06-01)

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study
by: Yi‐min Han, et al.
Published: (2023-06-01)

Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment
by: Simson DK, et al.
Published: (2018-03-01)

Response of various histological types of locally advanced rectal cancer to neoadjuvant multimodality therapy
by: Muhammad Sohaib Nadeem, et al.
Published: (2024-06-01)

Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer
by: Jason K. Douglas, et al.
Published: (2020-05-01)

Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response
by: Tae Hoon Lee, et al.
Published: (2023-07-01)

Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer
by: Victor Lopez-Lopez, et al.
Published: (2016-01-01)

Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
by: Ri Na Yoo, et al.
Published: (2019-07-01)

Deciphering the Dilemma: Choosing the Optimal Total Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
by: Erik Manriquez, et al.
Published: (2024-07-01)

Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01)

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER
by: S. R. Altybaev, et al.
Published: (2016-11-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
by: Chen M, et al.
Published: (2019-01-01)

Comparison of pathological response of standard chemoradiotherapy versus short course radiotherapy in rectal carcinoma: A pilot study
by: Bangalore Rammohan Nagarjun, et al.
Published: (2023-01-01)

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
by: Zhengfa Xue, et al.
Published: (2021-09-01)

Identification of hub genes predicting sensitivity to neoadjuvant chemoradiation in locally advanced rectal cancer
by: Zhao Qunye, et al.
Published: (2025-08-01)

A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer
by: Prachi S. Patil, et al.
Published: (2025-03-01)

Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma
by: Ali Shamseddine, et al.
Published: (2020-09-01)

Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery
by: Yahang Liang, et al.
Published: (2024-03-01)

Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice
by: Francesca Coppola, et al.
Published: (2021-04-01)

Survival outcomes of salvage surgery in the watch-and-wait approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
by: Wenjie Lin, et al.
Published: (2023-12-01)

Can we use a simple blood test to reduce unnecessary adverse effects from radiotherapy by timely identification of radiotherapy-resistant rectal cancers? MeD-Seq rectal study protocol
by: D. M. Mens, et al.
Published: (2023-12-01)

The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes
by: Gyu-Seog Choi, et al.
Published: (2024-08-01)

Robotic versus laparoscopic surgery for rectal cancer after neoadjuvant chemoradiotherapy: A propensity-score matching analysis
by: Tzu-Chun Chen, et al.
Published: (2022-08-01)

Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting
by: Wen‐Yang Liu, et al.
Published: (2023-05-01)

GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer
by: Tae Hyun Kim, et al.
Published: (2023-03-01)

Successful treatment of double malignant fistulas in advanced rectosigmoid junction tumor with neoadjuvant chemoradiation and surgery: A case report
by: Wen-Yu Chuang, et al.
Published: (2024-01-01)

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY
by: S. O. Kochkina, et al.
Published: (2021-08-01)

Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer
by: Virgílio Souza e Silva, et al.
Published: (2021-06-01)

The optimal time interval between neoadjuvant chemoradiotherapy and surgery for patients with an unfavorable pathological response in locally advanced rectal cancer: a retrospective cohort study
by: Litao Wang, et al.
Published: (2025-02-01)

Intensification of neoadjuvant therapy in patients with locally advanced rectal cancer
by: Z. Z. Mamedli, et al.
Published: (2021-11-01)

The impact of intensity‐modulated radiotherapy in conjunction with chemotherapy on proximal pT3N0 rectal cancer patients after total mesorectum excision
by: Chuan‐Yin Fang, et al.
Published: (2023-12-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
by: Marina Morais, et al.
Published: (2023-03-01)

Does Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer Increase Rate of Sphincter Preserving Surgery? A Prospective Clinical Trial
by: Wiroon Boonnuch, et al.
Published: (2006-04-01)

Neoadjuvant chemoradiation therapy for locally advanced colorectal cancer in hypofractionation mode (case report)
by: S. I. Tkachev, et al.
Published: (2019-11-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)